FIRA DE BARCELONA
| 2013 REPORT
Major medical and technological
congresses
In 2013 major congresses and corporate
meetings were held, especially medical and
technological, gathering more tan 100,000
participants. It is a strategic option of Fira
de Barcelona, both from the point of view of
business and from the point of view of offering
the organisers a wide range of services and
contributing to the city’s positioning in the field
of business tourism.
· 49th Congress of the European
Association for the Study of Diabetes
(EASD)
. It featured top experts in the
prevention, diagnosis and treatment of this
condition, affecting almost 400 million people in
the world, and considered as the main endocrine
disease of the 21st century, according to the
World Health Organization (WHO). It brought
together around 18,000 participants.
· Congress of the European Respiratory
Society (ERS)
. It dealt specifically with the
effects of smoking as one of the main causes
for pulmonary disease. The congress, already
held by Fira de Barcelona in 2010, featured
4,300 technical presentations and gathered
21,000 pulmonologists and other professionals.
· 23rd ENS Annual Meeting
. It presented
the most significant advances on neurological
research and therapy, with special attention
to Parkinson, multiple sclerosis, migraines,
attention disorder in adolescents, etc. It
gathered more than 3,000 participants.
Other medical congresses
Other events included the International
Conference on Innovative Approaches in Head
and Neck Oncology, the 35th Semergen National
Congress –a congress devoted to Family Care
and organised by the Spanish Society of Family
and Community Medicine, which brought
together 5,000 delegates– and the 24th National
Congress on Neonatology and Perinatal Medicine
together with the 4rth National Congress on
Neonatal Nursing, the most important meeting
on this specialty in Spain.
Likewise, experts on dermatology and
rheumatology from around the world gathered
at the event «Progress & Promise 2013», and
annual meeting hosted internationally by the
Pfizer laboratories with the aim of exchanging
Congresses
and other events
